Read the latest positive news, breakthroughs, and inspiring stories about sickle cell disease, curated daily by BrightWire.
Two breakthrough gene therapies approved in 2023 could free thousands of Americans from a lifetime of debilitating pain caused by sickle cell disease. While access barriers remain, medical experts say these treatments mark the beginning of a new era for the 100,000 people living with this genetic blood disorder.
After decades of pain and hospital visits, Toronto filmmaker Gabriel Badejo underwent an experimental stem cell treatment that could cure his sickle cell disease. He captured every moment on camera, creating a documentary about finally living without pain.
Scientists at Harvard discovered that blocking a protein called BACH2 could help treat sickle cell disease by boosting protective fetal hemoglobin levels. This breakthrough opens an entirely new treatment pathway that works differently from existing therapies.
Rwanda's doctors are calling for widespread sickle cell testing before couples have children, after seeing too many patients diagnosed only when life-threatening complications strike. Early treatment can prevent organ damage and transform outcomes for children living with the inherited blood disorder.
A 15-year-old girl became the first patient to receive a life-changing red blood cell exchange at Kenya's Defence Forces Memorial Hospital, opening access to advanced sickle cell treatment for military families. The breakthrough procedure uses new technology to replace damaged cells with healthy donor blood.
Researchers at Dana-Farber have identified a completely new pathway to activate healing fetal hemoglobin in blood disorder patients. The breakthrough could lead to safer, more accessible treatments beyond current gene therapies.
Thirteen young patients in New Jersey are celebrating more than a year without sickle cell disease after receiving groundbreaking bone marrow transplants or gene therapy. Their milestone marks a transformation from lives dominated by painful crises and hospital stays to normal childhoods full of school, play, and possibility.
A Senegalese lab is producing Africa's first locally made sickle cell treatment at one-third the cost of imported drugs. The breakthrough offers hope to 8 million patients worldwide, 80% of them in Africa.
A breakthrough program in Nigeria is preventing strokes in children with sickle cell disease using affordable screening and treatment. Over 150,000 Nigerian children are born with this painful condition each year, and now they have real hope.
A new gene therapy approach at Boston Children's Hospital collects and prepares sickle cell treatment in just seven weeks instead of six months, making life-changing care faster and more accessible. The breakthrough has already helped 36 patients and is expanding to Brazil and India.
Two young disease survivors will share their stories through an innovative dinner event that pairs each chapter of their journey with a custom dish and song. All proceeds support families battling childhood cancer and sickle cell disease.
The FDA just approved a groundbreaking gene-editing treatment that can cure sickle cell disease in children as young as two years old. A Nashville doctor who performed the world's first procedure in 2019 is now giving families hope after decades of painful, life-threatening complications.